BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10652580)

  • 1. Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors.
    Nakagawa T; Kabuto M; Kubota T; Kodera T; Sato K
    Anticancer Res; 1999; 19(4B):2963-8. PubMed ID: 10652580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine proteinase inhibitors in human skeletal muscle: expression of beta-amyloid protein precursor and alpha 1-antichymotrypsin in vivo and during myogenesis in vitro.
    Akaaboune M; Verdière-Sahuqué M; Lachkar S; Festoff BW; Hantaï D
    J Cell Physiol; 1995 Dec; 165(3):503-11. PubMed ID: 7593229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
    Erdamar S; Bagci P; Oz B; Dirican A
    J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-amyloid precursor protein accumulates in axons around hematogenous metastases of the human brain: immunohistochemical observations.
    Zhang M; Olsson Y
    Clin Neuropathol; 1996; 15(2):74-8. PubMed ID: 8925600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
    Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
    Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and release of CD14 in astrocytic brain tumors.
    Deininger MH; Meyermann R; Schluesener HJ
    Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
    Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
    Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
    Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
    Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocalyxin expression in malignant astrocytic tumors.
    Hayatsu N; Kaneko MK; Mishima K; Nishikawa R; Matsutani M; Price JE; Kato Y
    Biochem Biophys Res Commun; 2008 Sep; 374(2):394-8. PubMed ID: 18639524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-amyloid protein protein precursor expression in lacrimal glands and tear fluid.
    Van Setten GB; Nilsson L; Hahne S; Johnston JA; Kvanta A; Gandy SE; Näslund J; Nordstedt C
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2585-93. PubMed ID: 8977472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel processing of beta-amyloid precursor protein catalyzed by membrane type 1 matrix metalloproteinase releases a fragment lacking the inhibitor domain against gelatinase A.
    Higashi S; Miyazaki K
    Biochemistry; 2003 Jun; 42(21):6514-26. PubMed ID: 12767235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
    Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS
    Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
    Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
    Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of huperzine A on amyloid precursor protein processing and beta-amyloid generation in human embryonic kidney 293 APP Swedish mutant cells.
    Peng Y; Jiang L; Lee DY; Schachter SC; Ma Z; Lemere CA
    J Neurosci Res; 2006 Sep; 84(4):903-11. PubMed ID: 16862548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
    Mai J; Sameni M; Mikkelsen T; Sloane BF
    Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of highly sulfated keratan sulfate synthesized in malignant astrocytic tumors.
    Kato Y; Hayatsu N; Kaneko MK; Ogasawara S; Hamano T; Takahashi S; Nishikawa R; Matsutani M; Mishima K; Narimatsu H
    Biochem Biophys Res Commun; 2008 May; 369(4):1041-6. PubMed ID: 18329383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.